Changes to the Supply Agreement with Cann Group

GENERAL
Mon, Dec 04 2023 09:48 am

Rua Bioscience today announces that Cann Group has given 12 months’ notice to terminate its existing supply contract with Rua Bioscience.

In response to Cann’s decision, Rua Bioscience has engaged legal advice to consider options.

There have been recent quality issues with Cann’s export products, which had already prompted Rua Bioscience to proactively explore alternative supply partnerships.

In the last 12 months, Rua has placed emphasis on securing multiple additional supply pathways with particular emphasis on cultivating our unique genetics in Europe and Australia. We now have more surety that we can consistently supply patients in our key markets of Germany, Australia and New Zealand.

“While we appreciate the history we have had with Cann, we are committed to ensuring the continuity of our operations and maintaining the highest standards in product quality” said Paul Naske, CEO at Rua Bioscience. “

The new supply partnerships will improve supply chain effectiveness and contribute to the overall growth and success of the company.


ENDS


Announcement PDF


Markets News

NZX's profit slips, trading volumes lowest in nine years
Markets

NZX's profit slips, trading volumes lowest in nine years

But the stock exchange operator's revenue was up.

Markets

Market will decide Huntly's Future: Genesis

Coal maybe a dirty word, but it is needed to keep the lights on.

Market will decide Huntly's Future: Genesis
Markets

NZ sharemarket rises, aided by speculation of Fletcher sale

Top gainer of the day was Comvita, which added 25.7%, taking its share price to $2.25.

Gregor Thompson 22 Feb 2024
NZ sharemarket rises, aided by speculation of Fletcher sale